Deflaza Suspension 6 mg/5 ml contains Deflazacort 6 mg per 5 ml, a corticosteroid with potent anti-inflammatory and immunosuppressive properties. This oral suspension is specifically designed for patients who have difficulty swallowing tablets, particularly pediatric patients or elderly individuals requiring precise dose adjustments.
Deflazacort helps control inflammation and modulate immune system activity in a wide range of conditions. It is commonly used for chronic inflammatory diseases, autoimmune disorders, allergic reactions, and muscle-wasting conditions such as Duchenne muscular dystrophy. The suspension formulation ensures accurate dosing, flexibility, and ease of administration, making it suitable for long-term therapy.
By reducing the production of inflammatory mediators and suppressing immune overactivity, Deflaza Suspension alleviates symptoms such as pain, swelling, redness, and fatigue. It offers the benefits of a corticosteroid while maintaining a relatively favorable safety profile compared to traditional glucocorticoids, with lower risks of weight gain, fluid retention, or metabolic disturbances.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Deflaza Suspension 6 mg/5 ml is indicated for:
Pediatric and adult patients with chronic inflammatory conditions such as rheumatoid arthritis or juvenile idiopathic arthritis
Autoimmune disorders including lupus, dermatomyositis, and polymyositis
Severe allergic reactions and asthma exacerbations
Management of Duchenne muscular dystrophy to improve muscle strength and slow disease progression
Short-term treatment of acute inflammatory flare-ups
Provides potent anti-inflammatory and immunosuppressive effects
Reduces pain, swelling, and redness in affected areas
Supports muscle function in patients with Duchenne muscular dystrophy
Easy-to-administer oral suspension suitable for children and patients with swallowing difficulties
Flexible dosing allows precise titration for individual needs
Well-tolerated for both short-term and long-term therapy
Deflazacort binds to glucocorticoid receptors in target cells, promoting the production of anti-inflammatory proteins while suppressing pro-inflammatory cytokines. This dual mechanism reduces the activity of immune cells, controlling inflammation and preventing tissue damage. Additionally, deflazacort modulates abnormal immune responses, providing therapeutic benefits in autoimmune conditions.
The dosage of Deflaza Suspension 6 mg/5 ml should be individualized according to the patient’s age, weight, condition severity, and clinical response.
Shake the suspension well before each use to ensure uniform dosing.
Measure the prescribed dose accurately using a calibrated dosing syringe or spoon.
Administer orally, with or without food, at the same time each day.
Gradual dose tapering is recommended when discontinuing therapy to prevent adrenal insufficiency or withdrawal symptoms.
Use with caution in patients with diabetes, hypertension, osteoporosis, or gastrointestinal disorders.
Monitor for signs of infection during therapy, as immunosuppression can increase susceptibility.
Regular check-ups may be necessary to monitor blood pressure, blood sugar, and bone health.
Avoid abrupt discontinuation without medical supervision.
Inform your physician about all other medications to prevent potential drug interactions.
Deflaza Suspension 6 mg/5 ml is generally well tolerated. Side effects may include:
Mild weight gain or fluid retention
Elevated blood sugar levels
Mood swings or sleep disturbances
Increased susceptibility to infections
Long-term use may affect bone density
Most side effects are manageable with careful dosing and monitoring.
Store below 30°C in a cool, dry place, away from light and moisture. Keep the container tightly closed and out of reach of children.
Login Or Registerto submit your questions to seller
No none asked to seller yet